Status:

WITHDRAWN

Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)

Lead Sponsor:

Cristália Produtos Químicos Farmacêuticos Ltda.

Conditions:

Pain

Palliative Care

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

Eligible patients who agree to participate will migrate from oral opioids to transdermal patches and be followed for four weeks. Oral morphine will be provided as pain rescue medication. The patients ...

Eligibility Criteria

Inclusion

  • Male or female outpatients aged from 18 to 70 years with cancer chronic pain who received in the last 4 weeks at least 40 mg of oral morphine or equianalgesic dose of other opioids. If using adjuvant analgesics, these must be in stable doses in the last 4 weeks.

Exclusion

  • Life expectancy bellow 4 months;
  • Karnofsky score \< 60;
  • Hypersensitivity to opioids or patches;
  • Acute pain;
  • Non cancer pain;
  • Increased intracranial pressure;
  • Conditions that prevent the patient to understand the study directions and/or give his consent;
  • Neuromuscular disorders with increased risk of respiratory depression;
  • Impossibility to receive rescue oral morphine; active infections;
  • Fever;
  • Pregnancy and nursing;
  • Uncontrolled diabetes mellitus or arterial hypertension;
  • Need of anticoagulation;
  • Need to operate machines or vehicles;
  • Important skin disorders;
  • History of severe allergic reactions;
  • BMI ≥ 35;
  • Safety exams outrange;
  • Participation in another clinical trial within the last 2 months;
  • Investigator´s opinion.

Key Trial Info

Start Date :

November 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00959400

Start Date

November 1 2009

Last Update

July 16 2015

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Hospital Universitario da Universidade Federal do Maranhao

São Luís, Maranhão, Brazil, 65020-070

2

Instituto Nacional de Cancer - Hospital do Cancer I

Rio de Janeiro, Rio de Janeiro, Brazil, 20230-130

3

Hospital das Clinicas da Faculdade de Medicina da Universidade Estadual Paulista "Julio de Mesquita Filho" - Campus de Botucatu - Unesp

Botucatu, São Paulo, Brazil, 18618-970

4

Hospital A. C. Camargo

São Paulo, São Paulo, Brazil, 01509-010